150 related articles for article (PubMed ID: 36801852)
1. Primary Graft Dysfunction Is Associated With Development of Early Cardiac Allograft Vasculopathy, but Not Other Immune-mediated Complications, After Heart Transplantation.
Han J; Moayedi Y; Henricksen EJ; Waddell K; Valverde-Twiggs J; Kim D; Luikart H; Zhang BM; Teuteberg J; Khush KK
Transplantation; 2023 Jul; 107(7):1624-1629. PubMed ID: 36801852
[TBL] [Abstract][Full Text] [Related]
2. HLA sensitization is associated with an increased risk of primary graft dysfunction after heart transplantation.
Han J; Rushakoff J; Moayedi Y; Henricksen E; Lee R; Luikart H; Shalakhti O; Gragert L; Benck L; Malinoski D; Kobashigawa J; Teuteberg J; Khush KK; Patel J; Kransdorf E
J Heart Lung Transplant; 2024 Mar; 43(3):387-393. PubMed ID: 37802261
[TBL] [Abstract][Full Text] [Related]
3. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
[TBL] [Abstract][Full Text] [Related]
4. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
[TBL] [Abstract][Full Text] [Related]
5. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after heart transplantation.
Omrani O; Alawwami M; Buraiki J; Selimovic N
Ann Saudi Med; 2018; 38(2):97-104. PubMed ID: 29620542
[TBL] [Abstract][Full Text] [Related]
6. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
Lima B; Rajagopal K; Petersen RP; Shah AS; Soule B; Felker GM; Rogers JG; Lodge AJ; Milano CA
Circulation; 2006 Jul; 114(1 Suppl):I27-32. PubMed ID: 16820584
[TBL] [Abstract][Full Text] [Related]
7. Incidence of acute rejection and patient survival in combined heart-liver transplantation.
Zhao K; Wang R; Kamoun M; Callans L; Bremner R; Rame E; McLean R; Cevasco M; Olthoff KM; Levine MH; Shaked A; Abt PL
Liver Transpl; 2022 Sep; 28(9):1500-1508. PubMed ID: 35247292
[TBL] [Abstract][Full Text] [Related]
8. Complement (C1q) Binding De Novo Donor-Specific Antibodies and Cardiac-Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
Das BB; Lacelle C; Zhang S; Gao A; Fixler D
Transplantation; 2018 Mar; 102(3):502-509. PubMed ID: 28885488
[TBL] [Abstract][Full Text] [Related]
9. Role of HLA matching and donor specific antibody development in long-term survival, acute rejection and cardiac allograft vasculopathy.
Costa D; Picascia A; Grimaldi V; Amarelli C; Petraio A; Levi A; Di Donato M; Pirozzi AVA; Fiorito C; Moccia G; Gallo A; Strozziero M; Marra C; De Feo M; Cacciatore F; Maiello C; Napoli C
Transpl Immunol; 2024 Apr; 83():102011. PubMed ID: 38403197
[TBL] [Abstract][Full Text] [Related]
10. Cardiac allograft vasculopathy in pediatric heart transplant recipients does early-onset portend a worse prognosis?
Khoury M; Conway J; Gossett JG; Edens E; Soto S; Cantor R; Koehl D; Barnes A; Exil V; Glass L; Kirklin JK; Zuckerman WA
J Heart Lung Transplant; 2022 May; 41(5):578-588. PubMed ID: 35172937
[TBL] [Abstract][Full Text] [Related]
11. The effects of donor-specific antibody characteristics on cardiac allograft vasculopathy.
Wang M; Patel NJ; Zhang X; Kransdorf EP; Azarbal B; Kittleson MM; Czer LSC; Kobashigawa JA; Patel JK
Clin Transplant; 2021 Dec; 35(12):e14483. PubMed ID: 34546613
[TBL] [Abstract][Full Text] [Related]
12. Circulating growth differentiation factor-15 as a novel biomarker in heart transplant.
Tokavanich N; Sinphurmsukskul S; Kongruttanachok N; Thammanatsakul K; Sritangsirikul S; Ariyachaipanich A; Ongcharit P; Siwamogsatham S; Boonyaratavej S; Puwanant S
ESC Heart Fail; 2021 Aug; 8(4):3279-3285. PubMed ID: 34110100
[TBL] [Abstract][Full Text] [Related]
13. Immunological link between primary graft dysfunction and chronic lung allograft rejection.
Bharat A; Kuo E; Steward N; Aloush A; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
Ann Thorac Surg; 2008 Jul; 86(1):189-95; discussion 196-7. PubMed ID: 18573422
[TBL] [Abstract][Full Text] [Related]
14. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
[TBL] [Abstract][Full Text] [Related]
15. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study.
Loupy A; Coutance G; Bonnet G; Van Keer J; Raynaud M; Aubert O; Bories MC; Racapé M; Yoo D; Duong Van Huyen JP; Bruneval P; Taupin JL; Lefaucheur C; Varnous S; Leprince P; Guillemain R; Empana JP; Levine R; Naesens M; Patel JK; Jouven X; Kobashigawa J
Circulation; 2020 Jun; 141(24):1954-1967. PubMed ID: 32363949
[TBL] [Abstract][Full Text] [Related]
16. Effect of persistent versus transient donor-specific HLA antibodies on graft outcomes in pediatric cardiac transplantation.
Irving CA; Carter V; Gennery AR; Parry G; Griselli M; Hasan A; Kirk CR
J Heart Lung Transplant; 2015 Oct; 34(10):1310-7. PubMed ID: 26123951
[TBL] [Abstract][Full Text] [Related]
17. The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.
Moayedi Y; Truby LK; Foroutan F; Han J; Guzman J; Angleitner P; Sabatino M; Felius J; VAN Zyl JS; Rodenas-Alesina E; Fan CP; Devore AD; Miller R; Potena L; Zuckermann A; Farrero M; Chih S; Farr M; Hall S; Ross HJ; Khush KK
J Card Fail; 2024 Jun; 30(6):805-815. PubMed ID: 37907150
[TBL] [Abstract][Full Text] [Related]
18. Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death.
Ayer A; Truby LK; Schroder JN; Casalinova S; Green CL; Bishawi MA; Bryner BS; Milano CA; Patel CB; Devore AD
J Card Fail; 2023 Jan; 29(1):67-75. PubMed ID: 36351494
[TBL] [Abstract][Full Text] [Related]
19. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.
Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301
[TBL] [Abstract][Full Text] [Related]
20. Severe and Moderate Primary Graft Dysfunction in Adult Heart Recipients.
Stefen SP; Tenório DF; Cirillo GCG; Gaspar SF; Oliveira KAS; Gaiotto FA; Jatene FB
Braz J Cardiovasc Surg; 2023 Apr; 38(2):214-218. PubMed ID: 36592073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
